Bionaut Labs
Bionaut Labs is a clinical-stage medical robotics company headquartered in Los Angeles, California, developing "Bionauts" — remote-controlled, magnetically steered microscale robots roughly the size of a grain of rice that travel through tissue to deliver drugs, biologics and nucleic acids directly to targets deep in the brain and central nervous system. Founded in 2016 by CEO Michael Shpigelmacher, the company is pursuing treatments for malignant glioma, Dandy-Walker syndrome, Parkinson's disease and Huntington's disease, and has raised more than $80 million from investors including Khosla Ventures. Its product is a therapeutic device and navigation platform regulated as a medical device, not software sold to developers: Bionaut Labs operates no public API, developer portal, SDK or machine-readable contract of any kind.
Bionaut Labs is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Robotics, Healthcare, and Biotechnology.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API
Other 1
Properties that don't map to a standard resource type